Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
FDA Announces Change in Status of 12 Peptides (BPC-157, TB-500, MOTs-C, Epitalon, KPV, Semax, GHK-Cu injectable, Melanotan II, LL-37, DSIP, PEG-MGF, DiHexa)
These receptors are specialized for lipolysis and thermogenesis
Add $35.01 more to save 8% off Bundle & Save Discount applies automatically at checkout once your cart subtotal hits the tier
FDA drug approval is a full review process involving Phase IIII clinical trials, demonstrated safety and efficacy in humans, and post-market surveillance obligations
TB-500 occasionally causes mild headaches or fatigue during initial treatment
US$ 24.38
US$ 24.05
US$ 24.30
US$ 28.05
US$ 23.30
